EarningsQ3 2021 Earnings Report

Outlook Therapeutics (41O) Q3 2021 Earnings Report

8 Followers

DE:41O Q3 2021 EPS Results

Actual EPS-€1.22

Consensus EPS-€1.22

Beat/MissMet expectations

One Year Ago EPS-€0.52

Actual Revenue€0.00

Expected Revenue€283.03K

Beat/MissMissed by -€283.03K

YoY Revenue Growth―

QuarterQ3 2021

Date08/13/2021

TimeBefore Open

Conference CallFriday, August 13, 2021

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.052	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.383	79.55% (+0.30)
May 15, 2026	2026 (Q2)	-0.11 / -0.14	-0.348	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.775	75.28% (+0.58)
Dec 19, 2025	2025 (Q4)	-0.23 / -0.05	-0.766	93.18% (+0.71)
Aug 14, 2025	2025 (Q3)	-0.31 / -0.38	-0.723	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.47 / -0.35	-1.35	74.19% (+1.00)
Feb 14, 2025	2025 (Q1)	-0.66 / -0.78	-0.697	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.70 / -0.77	-0.871	12.00% (+0.10)
Aug 14, 2024	2024 (Q3)	-0.90 / -0.72	-1.393	48.13% (+0.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed